Xtant Medical Holdings Inc (XTNT)-製薬・医療分野:企業M&A・提携分析

【英語タイトル】Xtant Medical Holdings Inc (XTNT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA8013639)・商品コード:DATA8013639
・発行会社(調査会社):GlobalData
・発行日:2017年11月28日
・ページ数:48
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings, Inc. is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowrap, orbitalwrap HD, facet stabilization, milled cervical spacers, traditional allografts, hMatrix ADM, hMatrix PR ADM, and sports medicine. It utilizes sterile technology for manufacturing bacterin products. The company offers its products for the treatment of degenerative, traumatic, and deformity conditions for orthopedic and neurological applications. It operates in Louisiana, Maryland, Oregon, Illinois, Delaware, California, Florida, and New York. Xtant Medical is headquartered in Belgrade, Montana, the US.

Xtant Medical Holdings Inc (XTNT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Xtant Medical Holdings Inc, Medical Devices Deals, 2011 to YTD 2017 10
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 12
Equity Offering 12
Bacterin International Raises USD6.5 Million in Public Offering of Shares 12
Bacterin International Completes Private Placement Of Shares For US$4 Million 14
Bacterin International Completes Private Placement Of Shares For US$4.8 Million 15
Bacterin International Completes Private Placement Of Shares For US$3.9 Million 16
Bacterin International Completes Private Placement Of Shares For US$3 Million 17
Bacterin International Completes Private Placement Of US$1 Million 18
Bacterin International Completes Private Placement Of US$1.9 Million 19
Debt Offering 20
Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 20
Xtant Medical Holdings Inc – Key Competitors 21
Xtant Medical Holdings Inc – Key Employees 22
Xtant Medical Holdings Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Strategy And Business Planning 24
Oct 06, 2017: Xtant Medical Announces Consolidation of Fixation Operations to Montana and Closure of Dayton Facility 24
Jul 26, 2016: Xtant Medical Announces the Operations Expansion of Montana’s Tissue Processing Rooms 25
Financial Announcements 26
Nov 21, 2017: Xtant Medical Reports Third Quarter 2017 Financial Results 26
Aug 09, 2017: Xtant Medical Reports Second Quarter 2017 Financial Results 28
May 09, 2017: Xtant Medical Reports First Quarter Revenue of $22.1 million, 5% Growth Compared to the Prior Year Period 29
Mar 09, 2017: Xtant Medical Reports Record Fourth Quarter Revenue of $24.5 million, 10% Growth Compared to Prior Year Period 30
Jan 11, 2017: XTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue & Adjusted EBITDA 32
Nov 07, 2016: Xtant Medical Holdings Reports Record Third Quarter 2016 Results 33
Oct 11, 2016: Xtant Medical Pre-Announces Record Third Quarter 2016 Revenue 34
Aug 01, 2016: Xtant Medical Reports Second Quarter 2016 Results 35
Jul 20, 2016: Xtant Medical Pre-Announces Second Quarter 2016 Revenue and EBITDA 36
May 04, 2016: Xtant Medical Reports First Quarter 2016 Results 37
Apr 19, 2016: Xtant Medical Pre-Announces First Quarter 2016 Revenue 38
Jan 12, 2016: Xtant Medical Holdings Reports Preliminary Fourth Quarter 2015 Financial Results 39
Corporate Communications 40
Feb 22, 2017: Xtant Medical Announces Appointment of Carl O’Connell to Permanent CEO 40
Jan 23, 2017: Xtant Medical CEO Dan Goldberger announces resignation 41
Nov 01, 2016: Xtant Medical Receives Approval of Compliance Plan from NYSE MKT 42
Oct 06, 2016: Xtant Medical Announces the Appointment of Carl O’Connell as President 43
Aug 19, 2016: Xtant Medical Receives Non Compliance Notice from NYSE MKT 44
Jun 16, 2016: Xtant Medical Announces Changes to Its Executive Management and Board of Directors 45
Government and Public Interest 46
May 26, 2016: Xtant Medical completes new accounts receivable revolver credit facility with Silicon Valley Bank 46
Other Significant Developments 47
Aug 16, 2016: Xtant Medical Expands AR Credit Facility with Silicon Valley Bank 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Xtant Medical Holdings Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Xtant Medical Holdings Inc, Medical Devices Deals, 2011 to YTD 2017 10
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Bacterin International Raises USD6.5 Million in Public Offering of Shares 12
Bacterin International Completes Private Placement Of Shares For US$4 Million 14
Bacterin International Completes Private Placement Of Shares For US$4.8 Million 15
Bacterin International Completes Private Placement Of Shares For US$3.9 Million 16
Bacterin International Completes Private Placement Of Shares For US$3 Million 17
Bacterin International Completes Private Placement Of US$1 Million 18
Bacterin International Completes Private Placement Of US$1.9 Million 19
Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 20
Xtant Medical Holdings Inc, Key Competitors 21
Xtant Medical Holdings Inc, Key Employees 22
Xtant Medical Holdings Inc, Subsidiaries 23

★調査レポート[Xtant Medical Holdings Inc (XTNT)-製薬・医療分野:企業M&A・提携分析] (コード:DATA8013639)販売に関する免責事項を必ずご確認ください。
★調査レポート[Xtant Medical Holdings Inc (XTNT)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆